Aeris Capital logo

Aeris Capital

Europe, Zurich, Switzerland, Pfaffikon

Description

Aeris Capital AG is a private equity fund and financial advisor with locations in the United States and Switzerland.

Investor Profile

Aeris Capital has made 39 investments, with 0 in the past 12 months and 38% as lead.

Stage Focus

  • Series C (26%)
  • Series D (21%)
  • Series A (18%)
  • Series B (10%)
  • Series Unknown (8%)
  • Series E (8%)
  • Private Equity (5%)
  • Post Ipo Equity (3%)
  • Seed (3%)

Country Focus

  • United States (67%)
  • Germany (21%)
  • Canada (8%)
  • Switzerland (3%)
  • Israel (3%)

Industry Focus

  • Health Care
  • Medical
  • Biotechnology
  • Therapeutics
  • Mobile
  • Genetics
  • Advertising
  • Advertising Platforms
  • Native Advertising
  • Publishing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Aeris Capital frequently co-invest with?

venBio Partners
North America, California, United States, San Francisco
Co-Investments: 2
BioMedPartners
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 6
Mohr Davidow Ventures
North America, California, United States, San Mateo
Co-Investments: 5
Kleiner Perkins
North America, California, United States, Menlo Park
Co-Investments: 3
Aberdare Ventures
North America, California, United States, San Francisco
Co-Investments: 3
Employee Stock Option Fund
North America, California, United States, San Mateo
Co-Investments: 2
C
Europe, Baden-Wurttemberg, Germany, Heidelberg
Co-Investments: 4
EDBI
Asia, Central Region, Singapore, Singapore
Co-Investments: 4
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 4
Venrock
North America, California, United States, Palo Alto
Co-Investments: 3

Which angels does Aeris Capital often collaborate with?

DC
Europe, Zurich, Switzerland, Zürich
Shared Deals: 1
JM
North America, Florida, United States, Miami
Shared Deals: 1
Benjamin Kahn
Asia, Israel
Shared Deals: 1

What are some of recent deals done by Aeris Capital?

GenomeDx Biosciences

Vancouver, British Columbia, Canada

GenomeDx discovers, develops, and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care.

BiotechnologyGeneticsHealth CareMedicalOncologyPrecision Medicine
Series UnknownJun 27, 2017
Amount Raised: $6,254,241
Jiff

Mountain View, California, United States

Jiff is an enterprise health benefits platform that saves employers money.

Health CareMedicalMobile
Series CJun 7, 2016
Amount Raised: $17,700,000
Solstice Biologics

San Francisco, California, United States

Solstice Biologics is a biotech company that provides solutions for targeting and delivering nucleic acid therapeutics.

BiotechnologyMedicalTherapeutics
Series CDec 30, 2015
Amount Raised: $4,000,000
Affimed

Heidelberg, Baden-Wurttemberg, Germany

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

BiotechnologyClinical TrialsHealth CareMedicalTherapeutics
Post Ipo EquityOct 1, 2015
Amount Raised: $21,376,011
Jiff

Mountain View, California, United States

Jiff is an enterprise health benefits platform that saves employers money.

Health CareMedicalMobile
Series CMay 21, 2015
Amount Raised: $23,300,000
Curetis

Holzgerlingen, Baden-Wurttemberg, Germany

Curetis is a molecular diagnostic firm focused on the development and commercialization of tools for diagnosing severe infectious diseases.

BiotechnologyGeneticsHealth DiagnosticsMedical
Series BNov 20, 2014
Amount Raised: $18,187,725
Butterfly Network

Burlington, Massachusetts, United States

Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.

ElectronicsHealth CareMedical DevicePersonal Health
Series UnknownNov 2, 2014
Amount Raised: $100,000,000
Jiff

Mountain View, California, United States

Jiff is an enterprise health benefits platform that saves employers money.

Health CareMedicalMobile
Series BSep 23, 2014
Amount Raised: $18,300,000
Affimed

Heidelberg, Baden-Wurttemberg, Germany

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

BiotechnologyClinical TrialsHealth CareMedicalTherapeutics
Series ESep 2, 2014
Amount Raised: $15,700,000
Smaato

New York, New York, United States

Smaato is a digital ad tech platform that offers a free ad server and monetization solution.

AdvertisingAdvertising PlatformsMobileNative AdvertisingPublishing
Series EAug 5, 2014
Amount Raised: $25,000,000